These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21670459)

  • 1. Is breast conservation therapy superior to mastectomy for women with triple-negative breast cancers?
    Pignol JP; Rakovitch E; Olivotto IA
    J Clin Oncol; 2011 Jul; 29(21):2841-3. PubMed ID: 21670459
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.
    Abdulkarim BS; Cuartero J; Hanson J; Deschênes J; Lesniak D; Sabri S
    J Clin Oncol; 2011 Jul; 29(21):2852-8. PubMed ID: 21670451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional recurrence in patients with triple-negative breast cancer: preliminary results of a single institution study.
    Dragun AE; Pan J; Rai SN; Kruse B; Jain D
    Am J Clin Oncol; 2011 Jun; 34(3):231-7. PubMed ID: 20805742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer.
    Gabos Z; Thoms J; Ghosh S; Hanson J; Deschênes J; Sabri S; Abdulkarim B
    Breast Cancer Res Treat; 2010 Nov; 124(1):187-94. PubMed ID: 20814819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer in very young women.
    Liukkonen S; Leidenius M; Saarto T; Sjöström-Mattson J
    Eur J Surg Oncol; 2011 Dec; 37(12):1030-7. PubMed ID: 21937191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors.
    Chen X; Yu X; Chen J; Zhang Z; Tuan J; Shao Z; Guo X; Feng Y
    Cancer; 2013 Jul; 119(13):2366-74. PubMed ID: 23576181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
    J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nomogram to predict individual prognosis in node-negative breast carcinoma.
    Mazouni C; Spyratos F; Romain S; Fina F; Bonnier P; Ouafik LH; Martin PM
    Eur J Cancer; 2012 Nov; 48(16):2954-61. PubMed ID: 22658808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor characteristics and recurrence patterns in triple negative breast cancer: a comparison between younger (<65) and elderly (≥65) patients.
    Königsberg R; Pfeiler G; Klement T; Hammerschmid N; Brunner A; Zeillinger R; Singer C; Dittrich C
    Eur J Cancer; 2012 Nov; 48(16):2962-8. PubMed ID: 22647688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status of treatment for early-stage invasive breast cancer].
    Kásler M; Polgár C; Fodor J
    Orv Hetil; 2009 May; 150(22):1013-21. PubMed ID: 19465349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and survival analysis of T1mic, a, bN0M0 breast cancer.
    Li J; Liu X; Tong Z
    Jpn J Clin Oncol; 2012 Jun; 42(6):471-6. PubMed ID: 22493058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evidence-based radiotherapy in the treatment of early-stage invasive breast cancer: traditional clinical features and biomarkers].
    Fodor J
    Magy Onkol; 2009 Mar; 53(1):7-14. PubMed ID: 19318321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast conservation in patients with multiple ipsilateral synchronous cancers.
    Kaplan J; Giron G; Tartter PI; Bleiweiss IJ; Estabrook A; Smith SR
    J Am Coll Surg; 2003 Nov; 197(5):726-9. PubMed ID: 14585405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular class as a predictor of locoregional and distant recurrence in the neoadjuvant setting for breast cancer.
    Vargo JA; Beriwal S; Ahrendt GM; Soran A; Johnson RR; McGuire K; Bhargava R
    Oncology; 2011; 80(5-6):341-9. PubMed ID: 21791944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J
    Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative margin status improves local control in conservatively managed breast cancer patients.
    Obedian E; Haffty BG
    Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathologic risk factors of tumor recurrence in patients with node-negative early breast cancer after mastectomy.
    Lin PH; Yeh MH; Liu LC; Chen CJ; Tsui YC; Su CH; Wang HC; Liang JA; Chang HW; Wu HS; Yeh SP; Li LY; Chiu CF
    J Surg Oncol; 2013 Nov; 108(6):352-7. PubMed ID: 23996583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options.
    Gentilini O; Masullo M; Rotmensz N; Peccatori F; Mazzarol G; Smeets A; Simsek S; De Dosso S; Veronesi P; Intra M; Zurrida S; Viale G; Goldhirsch A; Veronesi U
    Eur J Surg Oncol; 2005 Apr; 31(3):232-6. PubMed ID: 15780556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
    Polgár C; Orosz Z; Kahán Z; Gábor G; Jani N; Cserni G; Hadijev J; Kulka J; Sulyok Z; Boross G; Lázár G; László Z; Diczházi C; Udvarhelyi N; Szabó E; Péntek Z; Major T; Fodor J
    Magy Onkol; 2008 Sep; 52(3):269-77. PubMed ID: 18845497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.